What is MELANOTAN-2?
Melanotan-2 (MT-2) is a synthetic, cyclic seven-amino-acid peptide classified as a structural analog of alpha-melanocyte-stimulating hormone (α-MSH). It is catalogued under CAS number 121062-08-6 and carries the molecular formula C50H69N15O9 with a molecular weight of 1024.18 g/mol. The compound is defined by the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, indicating an N-terminal acetyl cap, a C-terminal amide, and a lactam bridge that constrains the backbone into a cyclic conformation.
Structurally, the peptide incorporates several non-canonical features that distinguish it from a linear native sequence: a norleucine (Nle) residue at the N-terminus, a D-phenylalanine (D-Phe) substitution that inverts the stereochemistry at that position, and an intramolecular amide (lactam) cyclization between the aspartate and lysine side chains. These modifications increase the conformational rigidity and metabolic stability of the molecule relative to the parent hormone, which is a common design strategy in structure-activity research on melanocortin peptides.
Within the scientific literature, Melanotan-2 is studied as a non-selective melanocortin receptor ligand and is used as a reference tool compound in in-vitro melanocortin-system research and receptor-binding investigations. American Peptides supplies this material strictly as a research chemical for laboratory and analytical applications. It is not a drug, dietary supplement, cosmetic, or food, and it is not intended for human or veterinary use, diagnosis, or any in-vivo administration.
Reconstitution & handling
Melanotan-2 is supplied as a lyophilized (freeze-dried) powder that must be brought into solution before analytical or in-vitro work. Bacteriostatic or sterile water is the most common reconstitution solvent for this class of cyclic peptide; the ionizable arginine, histidine, and lysine side chains generally confer good aqueous solubility. To dissolve the material, the chosen solvent is directed slowly down the inner wall of the vial rather than injected directly onto the powder pellet, and the vial is then left to stand and swirled gently until the solution is clear. Vigorous shaking or vortexing is avoided because mechanical shear and foaming can stress the peptide backbone.
For sparingly soluble handling scenarios, a small volume of a mild acid such as dilute acetic acid can be used to aid initial dissolution before dilution into the working aqueous buffer, and the resulting stock can be adjusted or diluted as the experimental protocol requires. Reconstituted solutions should be prepared fresh where possible, kept cold during handling, and protected from prolonged light exposure given the tryptophan and histidine residues in the sequence, which are sensitive to oxidation. All reconstitution should be performed by trained personnel using appropriate laboratory technique.
Storage & stability
In its lyophilized form, Melanotan-2 is stable for extended periods when stored sealed, desiccated, and protected from light; long-term storage at -20°C is standard practice, and the dry powder tolerates brief periods at ambient shipping temperatures without meaningful degradation. Once reconstituted, the peptide is markedly less stable and should be held refrigerated at 2-8°C for near-term use or aliquoted and frozen at -20°C or below for longer intervals. Repeated freeze-thaw cycles are minimized by dividing the stock into single-use aliquots, since successive thawing accelerates aggregation and hydrolytic breakdown of the cyclic structure. Keeping solutions cold, dark, and sealed preserves peptide integrity across the working period.
How it's tested
Each lot of Melanotan-2 is characterized analytically to confirm identity and purity before release. Reversed-phase high-performance liquid chromatography (RP-HPLC) is used to quantify chromatographic purity, with material specified at ≥99% by HPLC. Molecular identity is confirmed by mass spectrometry (MS), where the observed mass is checked against the theoretical monoisotopic and average mass derived from the C50H69N15O9 formula (MW 1024.18) to verify that the intact cyclic sequence and its acetyl/amide modifications are present. A Certificate of Analysis (COA) documenting these results is available for the supplied lot, providing traceable, lot-specific verification of identity, purity, and quality parameters.